Disease | N. SNPs d | DSI v | DPI v | Chr | Position | Consequence | Alleles | Class | AFEXOME | AFGENOME | Score vda | EI vda | N. PMIDs | First Ref. | Last Ref. | ||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Disorder of eye
|
14 | 0.672 | 0.480 | 14 | 20454990 | non coding transcript exon variant | T/C;G | snv | 0.010 | 1.000 | 1 | 2015 | 2015 | ||||||
Fuchs Endothelial Dystrophy
|
32 | 0.672 | 0.480 | 14 | 20454990 | non coding transcript exon variant | T/C;G | snv | 0.010 | 1.000 | 1 | 2015 | 2015 | ||||||
Keratoconus
|
83 | 0.672 | 0.480 | 14 | 20454990 | non coding transcript exon variant | T/C;G | snv | 0.010 | 1.000 | 1 | 2015 | 2015 | ||||||
Childhood Osteosarcoma
|
151 | 0.672 | 0.480 | 14 | 20454990 | non coding transcript exon variant | T/C;G | snv | 0.010 | 1.000 | 1 | 2017 | 2017 | ||||||
Osteosarcoma of bone
|
151 | 0.672 | 0.480 | 14 | 20454990 | non coding transcript exon variant | T/C;G | snv | 0.010 | 1.000 | 1 | 2017 | 2017 | ||||||
Osteosarcoma
|
178 | 0.672 | 0.480 | 14 | 20454990 | non coding transcript exon variant | T/C;G | snv | 0.010 | 1.000 | 1 | 2017 | 2017 | ||||||
Conventional (Clear Cell) Renal Cell Carcinoma
|
222 | 0.672 | 0.480 | 14 | 20454990 | non coding transcript exon variant | T/C;G | snv | 0.010 | 1.000 | 1 | 2011 | 2011 | ||||||
Central neuroblastoma
|
231 | 0.672 | 0.480 | 14 | 20454990 | non coding transcript exon variant | T/C;G | snv | 0.010 | 1.000 | 1 | 2019 | 2019 | ||||||
Childhood Neuroblastoma
|
231 | 0.672 | 0.480 | 14 | 20454990 | non coding transcript exon variant | T/C;G | snv | 0.010 | 1.000 | 1 | 2019 | 2019 | ||||||
Renal Cell Carcinoma
|
288 | 0.672 | 0.480 | 14 | 20454990 | non coding transcript exon variant | T/C;G | snv | 0.010 | 1.000 | 1 | 2011 | 2011 | ||||||
Malignant neoplasm of ovary
|
315 | 0.672 | 0.480 | 14 | 20454990 | non coding transcript exon variant | T/C;G | snv | 0.010 | 1 | 2013 | 2013 | |||||||
Nasopharyngeal carcinoma
|
320 | 0.672 | 0.480 | 14 | 20454990 | non coding transcript exon variant | T/C;G | snv | 0.010 | 1.000 | 1 | 2018 | 2018 | ||||||
Carcinoma, Ovarian Epithelial
|
327 | 0.672 | 0.480 | 14 | 20454990 | non coding transcript exon variant | T/C;G | snv | 0.010 | 1 | 2013 | 2013 | |||||||
Neoplasm Metastasis
|
327 | 0.672 | 0.480 | 14 | 20454990 | non coding transcript exon variant | T/C;G | snv | 0.010 | 1.000 | 1 | 2017 | 2017 | ||||||
Neuroblastoma
|
386 | 0.672 | 0.480 | 14 | 20454990 | non coding transcript exon variant | T/C;G | snv | 0.010 | 1.000 | 1 | 2019 | 2019 | ||||||
Malignant neoplasm of stomach
|
615 | 0.672 | 0.480 | 14 | 20454990 | non coding transcript exon variant | T/C;G | snv | 0.010 | 1.000 | 1 | 2019 | 2019 | ||||||
Stomach Carcinoma
|
652 | 0.672 | 0.480 | 14 | 20454990 | non coding transcript exon variant | T/C;G | snv | 0.010 | 1.000 | 1 | 2019 | 2019 | ||||||
ovarian neoplasm
|
757 | 0.672 | 0.480 | 14 | 20454990 | non coding transcript exon variant | T/C;G | snv | 0.010 | 1 | 2013 | 2013 | |||||||
Primary malignant neoplasm of lung
|
981 | 0.672 | 0.480 | 14 | 20454990 | non coding transcript exon variant | T/C;G | snv | 0.030 | 1.000 | 3 | 2009 | 2014 | ||||||
Malignant neoplasm of lung
|
1142 | 0.672 | 0.480 | 14 | 20454990 | non coding transcript exon variant | T/C;G | snv | 0.030 | 1.000 | 3 | 2009 | 2014 | ||||||
Carcinoma of lung
|
1204 | 0.672 | 0.480 | 14 | 20454990 | non coding transcript exon variant | T/C;G | snv | 0.030 | 1.000 | 3 | 2009 | 2014 | ||||||
Primary malignant neoplasm
|
1374 | 0.672 | 0.480 | 14 | 20454990 | non coding transcript exon variant | T/C;G | snv | 0.010 | 1.000 | 1 | 2019 | 2019 | ||||||
Malignant Neoplasms
|
1641 | 0.672 | 0.480 | 14 | 20454990 | non coding transcript exon variant | T/C;G | snv | 0.010 | 1.000 | 1 | 2019 | 2019 | ||||||
Neoplasms
|
1644 | 0.672 | 0.480 | 14 | 20454990 | non coding transcript exon variant | T/C;G | snv | 0.010 | 1.000 | 1 | 2017 | 2017 | ||||||
Breast Carcinoma
|
2793 | 0.672 | 0.480 | 14 | 20454990 | non coding transcript exon variant | T/C;G | snv | 0.010 | 1.000 | 1 | 2018 | 2018 |